Negar Firoozi

As a member of Biogen's Bioassay Development & Analytics (BioDnA) group in the Analytical Development Department, I support the development, optimization, qualification, and troubleshooting of bioassays. Before this, I was part of the research team at Ayass Bioscience, where I worked on aptamer-NP complexes and pseudotyped particle production to study SARS-CoV-2. My work involved a range of techniques, including cell culture, plasmid construction, mutagenesis, cloning, generation of stable cell lines, nucleic acid extraction and purification, ELISA-based binding assays, PCR, Western blot, and protein purification.

Before joining Ayass Bioscience, I was a postdoctoral research associate at the UN Medical Center, where I studied the regulation of stem cells and their use in treating blinding diseases such as glaucoma and age-related macular degeneration. My Ph.D. research focused on biomaterials for tissue regeneration and drug delivery.

As an independent researcher and valuable team member, I bring strong leadership and effective communication skills to my work. I am always looking to expand my skills and knowledge to tackle new challenges in the field of biotechnology.

--------------------------------------------

Research Interests:

Bioassay Development, Tissue Engineering, Stem Cells, Microfluidic Devices, Biomaterials, Drug Delivery, Regenerative Medicine, Material Synthesis & Characterisation, Electrochemistry, Coating & Surface Modification